MB, Levis & Associates’s Mondelez International MDLZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$21.2K Buy
367
+1
+0.3% +$60 0.01% 145
2026
Q1
$21.1K Buy
366
+1
+0.3% +$58 0.01% 139
2025
Q4
$19.7K Hold
365
0.01% 141
2025
Q3
$22.8K Sell
365
-253
-41% -$16.3K 0.01% 137
2025
Q2
$41.7K Buy
618
+103
+20% +$6.87K 0.02% 129
2025
Q1
$34.9K Buy
515
+2
+0.4% +$123 0.02% 140
2024
Q4
$30.6K Buy
513
+2
+0.4% +$132 0.02% 142
2024
Q3
$37.7K Buy
511
+2
+0.4% +$141 0.02% 131
2024
Q2
$33.3K Buy
509
+1
+0.2% +$69 0.02% 133
2024
Q1
$35.6K Buy
508
+2
+0.4% +$146 0.02% 131
2023
Q4
$36.7K Buy
506
+1
+0.2% +$69 0.02% 128
2023
Q3
$35K Buy
505
+2
+0.4% +$144 0.02% 131
2023
Q2
$36.7K Buy
503
+1
+0.2% +$74 0.02% 133
2023
Q1
$35K Buy
502
+242
+93% +$16K 0.02% 136
2022
Q4
$17.4K Buy
+260
New +$16.4K 0.01% 157

Other funds holding MDLZ

MB, Levis & Associates's MDLZ Position: Q2 2026 in Review

MB, Levis & Associates increased its Mondelez International (MDLZ) stake by 0.27% in Q2 2026, buying an estimated $60 and bringing the position to 367 shares worth $21.2K. The position accounts for 0.01% of the portfolio, ranked #145.

MB, Levis & Associates first reported a position in MDLZ in Q4 2022 and has held it in 15 quarters since. The position peaked at $41.7K in Q2 2025. 608 funds tracked by Wall St. Rank hold MDLZ as of Q2 2026.

  • MB, Levis & Associates held 367 shares of Mondelez International worth $21.2K as of Q2 2026.
  • MB, Levis & Associates bought 1 Mondelez International share in Q2 2026, an estimated $60.
  • Mondelez International made up 0.01% of MB, Levis & Associates's portfolio in Q2 2026, its #145 holding.
  • MB, Levis & Associates first reported a position in Mondelez International in Q4 2022 and has held it in 15 quarters since.
  • MB, Levis & Associates's Mondelez International position peaked at $41.7K in Q2 2025.
  • 608 funds tracked by Wall St. Rank held Mondelez International as of Q2 2026.

Based on MB, Levis & Associates's 13F filing for Q2 2026, filed 22 Jul 2026.